Latest Trends in Lateral Flow Immunoassay (LFIA) Detection Labels and Conjugation Process

LFIA is one of the most successful analytical methods for various target molecules detection. As a recent example, LFIA tests have played an important role in mitigating the effects of the global pandemic with SARS-COV-2, due to their ability to rapidly detect infected individuals and stop further s...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in bioengineering and biotechnology 2022-06, Vol.10, p.922772-922772
Main Authors: Mirica, Andreea-Cristina, Stan, Dana, Chelcea, Ioana-Cristina, Mihailescu, Carmen Marinela, Ofiteru, Augustin, Bocancia-Mateescu, Lorena-Andreea
Format: Article
Language:English
Subjects:
bioconjugation
Bioengineering and Biotechnology
diagnostic
functionalization
LFIA
nanoparticles
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:LFIA is one of the most successful analytical methods for various target molecules detection. As a recent example, LFIA tests have played an important role in mitigating the effects of the global pandemic with SARS-COV-2, due to their ability to rapidly detect infected individuals and stop further spreading of the virus. For this reason, researchers around the world have done tremendous efforts to improve their sensibility and specificity. The development of LFIA has many sensitive steps, but some of the most important ones are choosing the proper labeling probes, the functionalization method and the conjugation process. There are a series of labeling probes described in the specialized literature, such as gold nanoparticles (GNP), latex particles (LP), magnetic nanoparticles (MNP), quantum dots (QDs) and more recently carbon, silica and europium nanoparticles. The current review aims to present some of the most recent and promising methods for the functionalization of the labeling probes and the conjugation with biomolecules, such as antibodies and antigens. The last chapter is dedicated to a selection of conjugation protocols, applicable to various types of nanoparticles (GNPs, QDs, magnetic nanoparticles, carbon nanoparticles, silica and europium nanoparticles).
ISSN:2296-4185
2296-4185
DOI:10.3389/fbioe.2022.922772